Digestive Diseases and Sciences

, Volume 54, Issue 2, pp 218–221 | Cite as

Adenovirus-Induced Acute Liver Failure

Stanford Multidisciplinary Seminars


International Normalize Ratio Acquire Immune Deficiency Syndrome Leptospirosis Cidofovir Hemorrhagic Cystitis 


  1. 1.
    Carrigan D. Adenovirus infections in immunocompromised patients. Am J Med. 1997;102:71–74. doi: 10.1016/S0002-9343(97)00015-6.PubMedCrossRefGoogle Scholar
  2. 2.
    Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262–274.PubMedGoogle Scholar
  3. 3.
    Chakrabarti S, Collingham KE, Fegan CD, Milligan DW. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant. 1999;23:1209–1211. doi: 10.1038/sj.bmt.1701788.PubMedCrossRefGoogle Scholar
  4. 4.
    Lenaerts L, Naesens L. Antiviral therapy for adenovirus infections. Antiviral Res. 2006;71:172–180. doi: 10.1016/j.antiviral.2006.04.007.PubMedCrossRefGoogle Scholar
  5. 5.
    Declercq ED. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev. 2003;16:569–596. doi: 10.1128/CMR.16.4.569-596.2003.CrossRefGoogle Scholar
  6. 6.
    Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transpl. 2007;123:74–81. doi: 10.1016/j.bbmt.2006.08.040.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Michael Rothenberg
    • 1
  • Ramsey Cheung
    • 1
  • Aijaz Ahmed
    • 1
  1. 1.Division of Gastroenterology and HepatologyStanford University Medical CenterStanfordUSA

Personalised recommendations